We are live on ! Find out more
GLRA

Gerald L. Ray & Associates Portfolio holdings

AUM $802M
1-Year Est. Return 21.01%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+21.01%
3 Year Est. Return
+38.23%
5 Year Est. Return
10 Year Est. Return
AUM
$657M
AUM Growth
-$7.35M
Cap. Flow
+$3.19M
Cap. Flow %
0.49%
Top 10 Hldgs %
28.46%
Holding
326
New
14
Increased
83
Reduced
96
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 25.53%
2 Industrials 12.9%
3 Consumer Staples 10.2%
4 Financials 8.89%
5 Technology 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMI icon
26
Kinder Morgan
KMI
$73.1B
$6.26M 0.95%
163,004
+2,649
+2% +$111K
PFE icon
27
Pfizer
PFE
$140B
$6.25M 0.95%
196,435
+329
+0.2% +$10.7K
MMP
28
DELISTED
Magellan Midstream Partners, L.P.
MMP
$6.06M 0.92%
82,624
+50
+0.1% +$4.01K
PM icon
29
Philip Morris
PM
$301B
$6.04M 0.92%
75,342
+1,045
+1% +$86K
XOM icon
30
ExxonMobil
XOM
$651B
$5.94M 0.9%
71,420
-3,069
-4% -$264K
SNDK
31
DELISTED
SANDISK CORP
SNDK
$5.73M 0.87%
98,470
-121
-0.1% -$8.1K
BA icon
32
Boeing
BA
$165B
$5.38M 0.82%
38,784
-208
-0.5% -$30.3K
IBM icon
33
IBM
IBM
$202B
$5.21M 0.79%
33,480
-264
-0.8% -$42.4K
EPD icon
34
Enterprise Products Partners
EPD
$83.8B
$5.14M 0.78%
171,925
-271
-0.2% -$8.87K
MSFT icon
35
Microsoft
MSFT
$2.84T
$4.95M 0.75%
112,197
-314
-0.3% -$14.3K
VRTX icon
36
Vertex Pharmaceuticals
VRTX
$121B
$4.86M 0.74%
39,370
-760
-2% -$95.8K
CAT icon
37
Caterpillar
CAT
$409B
$4.67M 0.71%
55,000
-783
-1% -$67.3K
CSCO icon
38
Cisco
CSCO
$450B
$4.58M 0.7%
166,761
-1,176
-0.7% -$33.7K
MRK icon
39
Merck
MRK
$324B
$4.44M 0.68%
81,775
-571
-0.7% -$32K
KSU
40
DELISTED
Kansas City Southern
KSU
$4.41M 0.67%
48,340
+500
+1% +$49.3K
TMO icon
41
Thermo Fisher Scientific
TMO
$211B
$4.41M 0.67%
33,971
+75
+0.2% +$9.78K
RTX icon
42
RTX Corp
RTX
$287B
$4.27M 0.65%
61,231
+1,192
+2% +$87.5K
SPG icon
43
Simon Property Group
SPG
$74.5B
$4.21M 0.64%
24,346
ACAD icon
44
Acadia Pharmaceuticals
ACAD
$4.25B
$4.14M 0.63%
98,950
-800
-0.8% -$31K
EL icon
45
Estee Lauder
EL
$29B
$3.92M 0.6%
45,234
ESRX
46
DELISTED
Express Scripts Holding Company
ESRX
$3.77M 0.57%
42,428
-729
-2% -$63.7K
CVX icon
47
Chevron
CVX
$388B
$3.44M 0.52%
35,702
+1,055
+3% +$111K
WFC icon
48
Wells Fargo
WFC
$261B
$3.41M 0.52%
60,638
+2,050
+3% +$114K
FDX icon
49
FedEx
FDX
$74.5B
$3.34M 0.51%
19,586
+140
+0.7% +$24.4K
LLY icon
50
Eli Lilly
LLY
$1.07T
$3.24M 0.49%
38,850

Similar funds

Gerald L. Ray & Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Gerald L. Ray & Associates held 326 positions worth $657M, down 1.1% from $665M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Gerald L. Ray & Associates's Q2 2015 filing shows 14 new, 83 increased, 96 reduced and 11 closed positions. Its largest new stake was Clearway Energy Class A: 23,497 shares worth $517K. The largest sale was Manitowoc, an estimated $975K.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Industrials and Consumer Staples.

  • Gerald L. Ray & Associates's largest Q2 2015 buy was Clearway Energy Class A: 23,497 shares worth $517K.
  • Gerald L. Ray & Associates added most to Twitter, Inc. in Q2 2015, an estimated $1.23M increase.
  • Gerald L. Ray & Associates's biggest Q2 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $566K.
  • Gerald L. Ray & Associates fully exited Manitowoc in Q2 2015, selling an estimated $975K.
  • Gerald L. Ray & Associates's ten largest holdings make up 28% of its $657M portfolio in Q2 2015.
  • Gerald L. Ray & Associates opened 14 new positions and closed 11 in Q2 2015.
  • Gerald L. Ray & Associates's portfolio value fell 1.1% quarter-over-quarter to $657M.

Based on Gerald L. Ray & Associates's 13F filing for Q2 2015, filed 3 Aug 2015.